1. Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK et al. (1989) Identification of the cystic fibrosis gene: genetic analysis. Science 245 (4922):1073-1080. doi:10.1126/science.2570460
2. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R et al. (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245 (4922):1066-1073. doi:10.1126/science.2475911
3. Rommens JM, Iannuzzi MC, Kerem B, Drumm ML, Melmer G et al. (1989) Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245 (4922):1059-1065. doi:10.1126/science.2772657
4. Dupuis A, Keenan K, Ooi CY, Dorfman R, Sontag MK et al. (2016) Prevalence of meconium ileus marks the severity of mutations of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene. Genetics in medicine : official journal of the American College of Medical Genetics 18 (4):333-340. doi:10.1038/gim.2015.79
5. Macdonald JA, Trusler GA (1960) Meconium ileus: an eleven-year review at the Hospital for Sick Children, Toronto. Canadian Medical Association journal 83 (17):881-885
6. Parikh NS, Ibrahim S, Ahlawat R (2021) Meconium Ileus. In: StatPearls. StatPearls Publishing
Copyright © 2021, StatPearls Publishing LLC., Treasure Island (FL),
7. Elborn JS (2016) Cystic fibrosis. Lancet 388 (10059):2519-2531. doi:10.1016/S0140-6736(16)00576-6
8. Cutting GR (2015) Cystic fibrosis genetics: from molecular understanding to clinical application. Nat Rev Genet 16 (1):45-56. doi:10.1038/nrg3849
9. Corvol H, Blackman SM, Boelle PY, Gallins PJ, Pace RG et al. (2015) Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis. Nat Commun 6:8382. doi:10.1038/ncomms9382
10. Jain-Vakkalagadda B, Pal D, Gunda S, Nashed Y, Ganapathy V et al. (2004) Identification of a Na+-dependent cationic and neutral amino acid transporter, B(0,+), in human and rabbit cornea. Mol Pharm 1 (5):338-346
11. Palazzolo L, Paravicini C, Laurenzi T, Adobati S, Saporiti S et al. (2019) SLC6A14, a Pivotal Actor on Cancer Stage: When Function Meets Structure. SLAS discovery : advancing life sciences R & D 24 (9):928-938. doi:10.1177/2472555219867317
12. Sloan JL, Mager S (1999) Cloning and functional expression of a human Na(+) and Cl(-)-dependent neutral and cationic amino acid transporter B(0+). J Biol Chem 274 (34):23740-23745. doi:10.1074/jbc.274.34.23740
13. Ruffin M, Mercier J, Calmel C, Mesinele J, Bigot J et al. (2020) Update on SLC6A14 in lung and gastrointestinal physiology and physiopathology: focus on cystic fibrosis. Cell Mol Life Sci 77 (17):3311-3323. doi:10.1007/s00018-020-03487-x
14. Coothankandaswamy V, Cao S, Xu Y, Prasad PD, Singh PK et al. (2016) Amino acid transporter SLC6A14 is a novel and effective drug target for pancreatic cancer. Br J Pharmacol 173 (23):3292-3306. doi:10.1111/bph.13616
15. Sun L, Rommens JM, Corvol H, Li W, Li X et al. (2012) Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis. Nat Genet 44 (5):562-569. doi:10.1038/ng.2221
16. Li W, Soave D, Miller MR, Keenan K, Lin F et al. (2014) Unraveling the complex genetic model for cystic fibrosis: pleiotropic effects of modifier genes on early cystic fibrosis-related morbidities. Hum Genet 133 (2):151-161. doi:10.1007/s00439-013-1363-7
17. Pereira SV, Ribeiro JD, Bertuzzo CS, Marson FAL (2017) Association of clinical severity of cystic fibrosis with variants in the SLC gene family (SLC6A14, SLC26A9, SLC11A1 and SLC9A3). Gene 629:117-126. doi:10.1016/j.gene.2017.07.068
18. Sun L, Rommens JM, Corvol H, Li W, Li X et al. (2012) Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis. 44 (5):562-569. doi:10.1038/ng.2221
19. Castellani C, Duff AJA, Bell SC, Heijerman HGM, Munck A et al. (2018) ECFS best practice guidelines: the 2018 revision. J Cyst Fibros 17 (2):153-178. doi:10.1016/j.jcf.2018.02.006
20. Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL et al. (2012) Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J 40 (6):1324-1343. doi:10.1183/09031936.00080312
21. Kulich M, Rosenfeld M, Campbell J, Kronmal R, Gibson RL et al. (2005) Disease-specific reference equations for lung function in patients with cystic fibrosis. Am J Respir Crit Care Med 172 (7):885-891. doi:10.1164/rccm.200410-1335OC
22. Bellec J, Bacchetta M, Losa D, Anegon I, Chanson M et al. (2015) CFTR inactivation by lentiviral vector-mediated RNA interference and CRISPR-Cas9 genome editing in human airway epithelial cells. Curr Gene Ther 15 (5):447-459
23. Di Paola M, Park AJ, Ahmadi S, Roach EJ, Wu YS et al. (2017) SLC6A14 Is a Genetic Modifier of Cystic Fibrosis That Regulates Pseudomonas aeruginosa Attachment to Human Bronchial Epithelial Cells. MBio 8 (6). doi:10.1128/mBio.02073-17
24. Ruffin M, Bilodeau C, Maillé É, LaFayette SL, McKay GA et al. (2016) Quorum-sensing inhibition abrogates the deleterious impact of Pseudomonas aeruginosa on airway epithelial repair. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 30 (9):3011-3025. doi:10.1096/fj.201500166R
25. Valera FCP, Ruffin M, Adam D, Maillé É, Ibrahim B et al. (2019) Staphylococcus aureus impairs sinonasal epithelial repair: Effects in patients with chronic rhinosinusitis with nasal polyps and control subjects. The Journal of allergy and clinical immunology 143 (2):591-603.e593. doi:10.1016/j.jaci.2018.05.035
26. Karunakaran S, Umapathy NS, Thangaraju M, Hatanaka T, Itagaki S et al. (2008) Interaction of tryptophan derivatives with SLC6A14 (ATB0,+) reveals the potential of the transporter as a drug target for cancer chemotherapy. Biochem J 414 (3):343-355. doi:10.1042/BJ20080622
27. Sikder MOF, Sivaprakasam S, Brown TP, Thangaraju M, Bhutia YD et al. (2020) SLC6A14, a Na+/Cl--coupled amino acid transporter, functions as a tumor promoter in colon and is a target for Wnt signaling. Biochem J 477 (8):1409-1425. doi:10.1042/BCJ20200099
28. Gong J, Wang F, Xiao B, Panjwani N, Lin F et al. (2019) Genetic association and transcriptome integration identify contributing genes and tissues at cystic fibrosis modifier loci. PLoS Genet 15 (2):e1008007. doi:10.1371/journal.pgen.1008007
29. Sikder MOF, Yang S, Ganapathy V, Bhutia YD (2017) The Na(+)/Cl(-)-Coupled, Broad-Specific, Amino Acid Transporter SLC6A14 (ATB(0,+)): Emerging Roles in Multiple Diseases and Therapeutic Potential for Treatment and Diagnosis. AAPS J 20 (1):12. doi:10.1208/s12248-017-0164-7
30. Sivaprakasam S, Sikder MOF, Ramalingam L, Kaur G, Dufour JM et al. (2021) SLC6A14 deficiency is linked to obesity, fatty liver, and metabolic syndrome but only under conditions of a high-fat diet. Biochim Biophys Acta Mol Basis Dis 1867 (5):166087. doi:10.1016/j.bbadis.2021.166087
31. Ahmadi S, Wu YS, Li M, Ip W, Lloyd-Kuzik A et al. (2019) Augmentation of Cystic Fibrosis Transmembrane Conductance Regulator Function in Human Bronchial Epithelial Cells via SLC6A14-Dependent Amino Acid Uptake. Implications for Treatment of Cystic Fibrosis. American journal of respiratory cell and molecular biology 61 (6):755-764. doi:10.1165/rcmb.2019-0094OC
32. Hibbard HAJ, Reynolds MM (2019) Fluorescent nitric oxide donor for the detection and killing of Pseudomonas aeruginosa. Journal of materials chemistry B 7 (12):2009-2018. doi:10.1039/c8tb02552e
33. Ahmadi S, Xia S, Wu YS, Di Paola M, Kissoon R et al. (2018) SLC6A14, an amino acid transporter, modifies the primary CF defect in fluid secretion. Elife 7. doi:10.7554/eLife.37963
34. Ruffin M, Brochiero E (2019) Repair Process Impairment by Pseudomonas aeruginosa in Epithelial Tissues: Major Features and Potential Therapeutic Avenues. Front Cell Infect Microbiol 9:182. doi:10.3389/fcimb.2019.00182
35. Mao H, Sheng J, Jia J, Wang C, Zhang S et al. (2021) Aberrant SLC6A14 Expression Promotes Proliferation and Metastasis of Colorectal Cancer via Enhancing the JAK2/STAT3 Pathway. Onco Targets Ther 14:379-392. doi:10.2147/OTT.S288709
36. Liu GY, Sabatini DM (2020) mTOR at the nexus of nutrition, growth, ageing and disease. Nat Rev Mol Cell Biol 21 (4):183-203. doi:10.1038/s41580-019-0199-y
37. Kaur H, Moreau R (2019) Role of mTORC1 in intestinal epithelial repair and tumorigenesis. Cellular and molecular life sciences : CMLS 76 (13):2525-2546. doi:10.1007/s00018-019-03085-6
38. Raslan AA, Yoon JK (2020) WNT Signaling in Lung Repair and Regeneration. Molecules and cells 43 (9):774-783. doi:10.14348/molcells.2020.0059